FGEN
FibroGen Inc
Price:  
1.71 
USD
Volume:  
2,186,537.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN Relative Valuation

-4736.2%
Upside

As of 2024-03-01, the Relative Valuation of FibroGen Inc (FGEN) is (79.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.71 USD, the upside of FibroGen Inc based on Relative Valuation is -4736.2%.

The range of the Relative Valuation is (71.20) - (78.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.8x - 28.7x 26.8x
Forward P/E multiples 22.0x - 26.3x 26.2x
Fair Price (71.20) - (78.74) (79.28)
Upside -4263.8% - -4704.7% -4736.2%
1.71 USD
Stock Price
(79.28) USD
Fair Price

FGEN Relative Valuation - Historical P/E Data

Date P/E
2024-02-29 -0.57
2024-02-28 -0.66
2024-02-27 -0.71
2024-02-26 -0.62
2024-02-23 -0.61
2024-02-22 -0.63
2024-02-21 -0.57
2024-02-20 -0.60
2024-02-16 -0.73
2024-02-15 -0.72
2024-02-14 -0.75
2024-02-13 -0.73
2024-02-12 -0.91
2024-02-09 -0.91
2024-02-08 -0.80
2024-02-07 -0.73
2024-02-06 -0.64
2024-02-05 -0.68
2024-02-02 -0.62
2024-02-01 -0.79
2024-01-31 -0.64
2024-01-30 -0.57
2024-01-29 -0.57
2024-01-26 -0.31
2024-01-25 -0.37
2024-01-24 -0.32
2024-01-23 -0.30
2024-01-22 -0.29
2024-01-19 -0.25
2024-01-18 -0.27
2024-01-17 -0.25
2024-01-16 -0.25
2024-01-12 -0.25
2024-01-11 -0.27
2024-01-10 -0.28
2024-01-09 -0.30
2024-01-08 -0.26
2024-01-05 -0.25
2024-01-04 -0.25
2024-01-03 -0.27
2024-01-02 -0.28
2023-12-29 -0.30
2023-12-28 -0.30
2023-12-27 -0.27
2023-12-26 -0.27
2023-12-22 -0.25
2023-12-21 -0.23
2023-12-20 -0.19
2023-12-19 -0.21
2023-12-18 -0.21